Literature DB >> 24715623

An improved method for estimating the heart-to-mediastinum ratio from cardiac sympathetic nerve imaging with low-energy high-resolution collimators.

Yusuke Inoue1, Yutaka Abe, Yuji Asano, Kei Kikuchi, Keiji Matsunaga, Takahiro Iizuka, Kazutoshi Nishiyama.   

Abstract

BACKGROUND: Septal penetration causes underestimation of the heart-to-mediastinum (H/M) ratio in cardiac (123)I-metaiodobenzylguanidine (MIBG) imaging with a low-energy high-resolution (LEHR) collimator. We aimed to improve the method of estimating the H/M ratios using the LEHR collimator. METHODS AND
RESULTS: 4 hours after (123)I-MIBG injection, 40 patients were imaged successively with the medium-energy (ME) and LEHR collimators using gamma cameras having 3/8-inch crystals. Severe underestimation of the H/M ratios was observed with the LEHR collimator when compared to the ME collimator. Narrowing the energy window width did not reduce the underestimation. Application of (123)I-dual-window (IDW) correction using a narrow or wide subwindow reduced the underestimation substantially but not entirely. The H/M ratios estimated from the LEHR images with or without IDW correction were corrected based on their correlations with the ratios estimated from the ME images. This empiric correction removed systematic underestimation, and residual errors were reduced when the H/M ratios after IDW correction were converted using the empiric equation. The conversion equation was successfully applied to the correction of the H/M ratios determined in another 40 patients using a 5/8-inch crystal.
CONCLUSIONS: In estimating the H/M ratios using an LEHR collimator, empiric correction combined with IDW correction improves concordance with ME-based values in comparison with empiric correction alone.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24715623     DOI: 10.1007/s12350-014-9893-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  16 in total

1.  Physical characteristics of low and medium energy collimators for 123I imaging and simultaneous dual-isotope imaging.

Authors:  Y Inoue; I Shirouzu; T Machida; Y Yoshizawa; F Akita; I Doi; T Watadani; M Noda; K Yoshikawa; K Ohtomo
Journal:  Nucl Med Commun       Date:  2003-11       Impact factor: 1.690

Review 2.  Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis.

Authors:  Giorgio Treglia; Ernesto Cason
Journal:  J Neuroimaging       Date:  2010-11-17       Impact factor: 2.486

3.  Comparison of low- and medium-energy collimators for SPECT imaging with iodine-123-labeled antibodies.

Authors:  D J Macey; G L DeNardo; S J DeNardo; H H Hines
Journal:  J Nucl Med       Date:  1986-09       Impact factor: 10.057

4.  Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.

Authors:  Arnold F Jacobson; Roxy Senior; Manuel D Cerqueira; Nathan D Wong; Gregory S Thomas; Victor A Lopez; Denis Agostini; Fred Weiland; Harish Chandna; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2010-02-25       Impact factor: 24.094

5.  Optimal collimator choice for sequential iodine-123 and technetium-99m imaging.

Authors:  F D Geeter; P R Franken; M Defrise; H Andries; E Saelens; A Bossuyt
Journal:  Eur J Nucl Med       Date:  1996-07

Review 6.  Cardiac sympathetic imaging with mIBG in heart failure.

Authors:  Ignasi Carrió; Martin R Cowie; Junichi Yamazaki; James Udelson; Paolo G Camici
Journal:  JACC Cardiovasc Imaging       Date:  2010-01

7.  Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations.

Authors:  Shinro Matsuo; Kenichi Nakajima; Koichi Okuda; Masaya Kawano; Takehiro Ishikawa; Tetsuo Hosoya; Junichi Taki; Seigo Kinuya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-07       Impact factor: 9.236

8.  Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake.

Authors:  Yusuke Inoue; Akira Suzuki; Ichiro Shirouzu; Toru Machida; Yasunori Yoshizawa; Fumihide Akita; Satoshi Ohnishi; Kohki Yoshikawa; Kuni Ohtomo
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

9.  Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio.

Authors:  Kenichi Nakajima; Kosuke Matsubara; Takehiro Ishikawa; Nobutoku Motomura; Ryo Maeda; Nasima Akhter; Koichi Okuda; Junichi Taki; Seigo Kinuya
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

10.  A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.

Authors:  Tomoaki Nakata; Kenichi Nakajima; Shohei Yamashina; Takahisa Yamada; Mitsuru Momose; Shu Kasama; Toshiki Matsui; Shinro Matsuo; Mark I Travin; Arnold F Jacobson
Journal:  JACC Cardiovasc Imaging       Date:  2013-07
View more
  3 in total

1.  Evaluation of myocardial sympathetic innervation in the 21st century: Is there a role for planar 123I-MIBG imaging?

Authors:  Riccardo Liga; Veronica Della Tommasina
Journal:  J Nucl Cardiol       Date:  2016-06-01       Impact factor: 5.952

Review 2.  Standardization of 123I-meta-iodobenzylguanidine myocardial sympathetic activity imaging: phantom calibration and clinical applications.

Authors:  Kenichi Nakajima; Derk O Verschure; Koichi Okuda; Hein J Verberne
Journal:  Clin Transl Imaging       Date:  2017-05-04

3.  Correction of collimator-dependent differences in the heart-to-mediastinum ratio in 123I-metaiodobenzylguanidine cardiac sympathetic imaging: Determination of conversion equations using point-source imaging.

Authors:  Yusuke Inoue; Yutaka Abe; Kei Kikuchi; Keiji Matsunaga; Ray Masuda; Kazutoshi Nishiyama
Journal:  J Nucl Cardiol       Date:  2016-06-01       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.